Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pauliina Rumm"'
Autor:
Paul Naaber, Kaidi Hunt, Jaana Pesukova, Liis Haljasmägi, Pauliina Rumm, Pärt Peterson, Jelena Hololejenko, Irina Eero, Piia Jõgi, Karolin Toompere, Epp Sepp
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0237548 (2020)
SARS-CoV-2 antibody tests are available in various formats, detecting different viral target proteins and antibody subclasses. The specificity and sensitivity of SARS-CoV-2 antibody tests are known to vary and very few studies have addressed the perf
Externí odkaz:
https://doaj.org/article/e4d4ffdc262d4bb4b274ae69ae35ceeb
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
Autor:
Jaanika Kärner, Kai Kisand, Ainika Adamson, Liina Tserel, Pärt Peterson, Kadri Kangro, Mart Ustav, Joachim M. Gerhold, Liis Haljasmägi, Paul Naaber, Anna Pauliina Rumm, Epp Sepp, Virge Jürjenson, Regina Maruste, Anu Planken
Publikováno v:
The Lancet Regional Health. Europe
Background SARS-CoV-2 mRNA vaccines have proven high efficacy, however, limited data exists on the duration of immune responses and their relation to age and side effects. Methods We studied the antibody and memory T cell responses after the two-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba4f81a2b8db6fe984ebced088e158c
https://pubmed.ncbi.nlm.nih.gov/34514454
https://pubmed.ncbi.nlm.nih.gov/34514454
Autor:
Paul Naaber, Joachim M. Gerhold, Jaanika Kärner, Jürjenson, Kadri Kangro, Anu Planken, Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Epp Sepp, Liina Tserel, Pärt Peterson, Mart Ustav, Ainika Adamson, Kalle Kisand
BackgroundAlthough the SARS-CoV-2 mRNA vaccines have proven high efficacy, limited data exists on the duration of immune responses and their relation to age and side effects.MethodsWe studied the antibody and memory T cell responses to Spike protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683065c7382577c36f50c06a63f3285d
https://doi.org/10.1101/2021.04.19.21255714
https://doi.org/10.1101/2021.04.19.21255714
Autor:
Lauri Kareinen, Anna Pauliina Rumm, Liis Haljasmägi, Pärt Peterson, Meeri Jürgenson, Ekaterina Krassohhina, Lili Milani, Adrian Hayday, Hanna Sein, Olli Vapalahti, Tarja Sironen, Hedi Peterson, Anu Remm, Kai Kisand, Anu Tamm, Ahto Salumets
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports
Scientific Reports
SARS-CoV-2 infection risks developing into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0035cfa053d992ce8907e3c929a0cd8b
https://doi.org/10.1038/s41598-020-77525-w
https://doi.org/10.1038/s41598-020-77525-w
Autor:
Pauliina Rumm, Paul Naaber, Epp Sepp, Pärt Peterson, Kaidi Hunt, Liis Haljasmägi, Jelena Hololejenko, Jaana Pesukova, Irina Eero, Karolin Toompere, Piia Jõgi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0237548 (2020)
PLoS ONE, Vol 15, Iss 10, p e0237548 (2020)
SARS-CoV-2 antibody tests are available in various formats, detecting different viral target proteins and antibody subclasses. The specificity and sensitivity of SARS-CoV-2 antibody tests are known to vary and very few studies have addressed the perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8d907ff25b2bfaf3f12ea241a3d137
http://europepmc.org/articles/PMC7591045
http://europepmc.org/articles/PMC7591045
Autor:
Jaana Pesukova, Kaidi Hunt, Irina Eero, Pauliina Rumm, Liis Haljasmägi, Piia Jõgi, Paul Naaber, Karolin Toompere, Epp Sepp, Jelena Hololejenko, Pärt Peterson
SummaryBackgroundHigh number of SARS-CoV-2 antibody tests are available in different formats, detect different types of antibodies, and use different target proteins. Sensitivity of these tests varies and could be also related to clinical symptoms an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfc26263db45be8ea33ee315be97a47
https://doi.org/10.1101/2020.07.15.20149617
https://doi.org/10.1101/2020.07.15.20149617
Autor:
Anu Remm, Anna Pauliina Rumm, Kai Kisand, Pärt Peterson, Ekaterina Krassohhina, Liis Haljasmägi, Anu Tamm, Hanna Sein
Publikováno v:
European Journal of Immunology
Profiling antibodies to SARS‐CoV‐2 can help to assess potential immune response after COVID‐19 disease. Luciferase IP system (LIPS) assay is a sensitive method for quantitative detection of antibodies to antigens in their native conformation. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265227e4535a10167c08570ba94ec879
https://pubmed.ncbi.nlm.nih.gov/32584420
https://pubmed.ncbi.nlm.nih.gov/32584420
Autor:
Liis Haljasmägi, Ahto Salumets, Anna Pauliina Rumm, Meeri Jürgenson, Ekaterina Krassohhina, Anu Remm, Hanna Sein, Lauri Kareinen, Olli Vapalahti, Tarja Sironen, Hedi Peterson, Lili Milani, Anu Tamm, Adrian Hayday, Kai Kisand, Pärt Peterson
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring inte
Externí odkaz:
https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac